Analyst firms · Barclays · RPD
Barclays RPD price target and rating history
Rapid7 Inc. (RPD) · Technology
Barclays rates Rapid7 Inc. (RPD) Underweight with a $15 price target, as of its latest action on Jan 5, 2026. It has published 4 rating actions on RPD since July 2021, including 0 upgrades and 2 downgrades. Across 6 firms with a RPD price target in the last 12 months, the median target is $12.50. Barclays's $15 is 20% above that.
- Current rating
- Underweight
- Price target
- $15
- Median target, all firms
- $12.50
- Actions on RPD
- 4
Barclays price target on RPD
Every Barclays rating on RPD
- Jan 5, 2026
- Jan 4, 2023
- Feb 10, 2022
- Jul 15, 2021
How other firms rate RPD
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Morgan Stanley | Underweight | $9 | Jul 21, 2026 |
| William Blair | Mkt Perform | Apr 29, 2026 | |
| UBS | Neutral | $9 | Feb 11, 2026 |
| Canaccord Genuity | Hold | $10 | Feb 11, 2026 |
| Citigroup | Neutral | $15 | Jan 13, 2026 |
| Barclays | Underweight | $15 | Jan 5, 2026 |
| Berenberg | Hold | $16 | Nov 18, 2025 |
Questions about Barclays and RPD
- What is Barclays's price target for RPD?
- Barclays's latest stated price target for Rapid7 Inc. (RPD) is $15, from its action on Jan 5, 2026.
- What is Barclays's rating on RPD?
- Barclays rates RPD Underweight, a bearish rating, as of Jan 5, 2026.
- When did Barclays last change its view on RPD?
- On Jan 5, 2026, Barclays downgrades to Underweight from Equal Weight, price target $15.
- How does Barclays's RPD target compare with other analysts?
- Across 6 firms with a RPD price target in the last 12 months, the median target is $12.50. Barclays's $15 is 20% above that.
More RPD rating histories
- Morgan Stanley5
- UBS3
- Canaccord Genuity4
- Citigroup3
- RBC Capital Markets5
- Wolfe Research3
- KeyBanc Capital Markets5
- Mizuho4
- Needham4
All Barclays ratingsRPD news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.